Roka Bioscience (ROKA) Reports Narrower Q2 Loss

Go back to Roka Bioscience (ROKA) Reports Narrower Q2 Loss

BofA/Merrill Lynch Starts Roka Bioscience (ROKA) at Buy

August 11, 2014 10:55 AM EDT

BofA/Merrill Lynch initiates coverage on Roka Bioscience (NASDAQ: ROKA) with a Buy rating and a price target of $14.00.

Analyst Derik de Bruin is bullish on the company's platform and prospects and he sees upside potential from expanding into new... More

Wedbush Starts Roka Bioscience (ROKA) at Outperform

August 11, 2014 7:33 AM EDT

Wedbush initiates coverage on Roka Bioscience (NASDAQ: ROKA) with a Outperform rating and a price target of $15.00.

Analyst Zarak Khurshid said, "ROKA is a pure-play diagnostics company focused on the food safety industry.... More

Cowen Starts Roka Bioscience (ROKA) at Outperform

August 11, 2014 6:44 AM EDT

Cowen initiated coverage on Roka Bioscience (NASDAQ: ROKA) with an Outperform rating and a price target of $13.00.

For an analyst ratings summary and ratings history on Roka Bioscience click here. For more ratings news on Roka Bioscience click here.

Shares of Roka Bioscience closed at $10.49 yesterday.

... More

Leerink Swann Starts Roka Bioscience (ROKA) at Outperform

August 11, 2014 6:44 AM EDT

Leerink Swann initiated coverage on Roka Bioscience (NASDAQ: ROKA) with an Outperform rating and a price target of $13.00.

For an analyst ratings summary and ratings history on Roka Bioscience click here. For more ratings news on Roka Bioscience click here.

Shares of Roka Bioscience closed at $10.49 yesterday.

... More